EODData

NASDAQ, RAPT: Rapt Therapeutics Inc

11 Dec 25 13:45
LAST:

36.54

CHANGE:
 0.09
OPEN:
36.31
HIGH:
37.50
ASK:
0.00
VOLUME:
82.6K
CHG(%):
0.23
PREV:
36.62
LOW:
36.07
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Dec 2536.3137.5036.0736.5482.6K
10 Dec 2535.1237.2934.2536.62473.9K
09 Dec 2534.5635.6434.3135.32292.4K
08 Dec 2534.8035.7334.0134.94416.3K
05 Dec 2534.4735.7233.9034.47363.6K
04 Dec 2532.0834.7331.7234.47441.0K
03 Dec 2532.2532.5031.2432.09343.2K
02 Dec 2531.5232.4030.0032.33815.0K
01 Dec 2533.5633.5631.4431.51219.7K
28 Nov 2533.2635.1032.1733.80353.0K

PROFILE

Name:Rapt Therapeutics Inc
About:RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:561 Eccles Avenue, South San Francisco, CA, United States, 94080
Website:https://www.rapt.com
CUSIP:75382E109
CIK:0001673772
ISIN:US75382E1091
FIGI:BBG00PGK50M2
LEI:549300MB473BIU78ES48

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-1.15 
Forward P/E:-15.98 
PEG Ratio:0.01 
Price to Sales:411.22 
Price to Book:3.04 
Return on Assets:-0.46 
Return on Equity:-0.78 
EPS Ratio:-14.80 
Shares:16.54M 
Market Cap:604.21M 

TECHNICAL INDICATORS

MA5:35.552.8%
MA10:34.196.8%
MA20:31.5315.9%
MA50:30.2021.0%
MA100:22.3463.5%
MA200:12.67188.5%
STO9:81.64 
STO14:89.44 
RSI14:80.34 
WPR14:-2.31 
MTM14:9.32
ROC14:0.34 
ATR:2.24 
Week High:37.502.6%
Week Low:31.7215.2%
Month High:37.502.6%
Month Low:26.50188.5%
Year High:42.3916.0%
Year Low:0.715,058.9%
Volatility:12.73 

RECENT SPLITS

Date Ratio
17 Jun 20251-8